|
1.
|
JP DesprésI LemieuxAbdominal obesity and
metabolic syndromeNature4448818872006
|
|
2.
|
SP WeisbergD McCannM DesaiM RosenbaumRL
LeibelAW Ferrante JrObesity is associated with macrophage
accumulation in adipose tissueJ Clin
Invest11217961808200310.1172/JCI20031924614679176
|
|
3.
|
H WuXD PerrardQ WangJL PerrardVR PolsaniPH
JonesCW SmithCM BallantyneCD11c expression in adipose tissue and
blood and its role in diet-induced obesityArterioscler Thromb Vasc
Biol30186192201010.1161/ATVBAHA.109.19804419910635
|
|
4.
|
AJ SanyalAGA technical review on
nonalcoholic fatty liver
diseaseGastroenterology12317051725200210.1053/gast.2002.3657212404245
|
|
5.
|
E FabbriniS SullivanS KleinObesity and
nonalcoholic fatty liver disease: biochemical, metabolic, and
clinical
implicationsHepatology51679689201010.1002/hep.2328020041406
|
|
6.
|
H TilgAR MoschenEvolution of inflammation
in nonalcoholic fatty liver disease: the multiple parallel hits
hypothesisHepatology5218361846201010.1002/hep.2400121038418
|
|
7.
|
S WangA Kama tP PergolaA SwamyF TioK
CusiMetabolic factors in the development of hepatic steatosis and
altered mitochondrial gene expression in
vivoMetabolism6010901099201110.1016/j.metabol.2010.12.00121310443
|
|
8.
|
J ChenD LiuQ BaiJ SongJ GuanJ GaoB LiuX
MaY DuCelecoxib attenuates liver steatosis and inflammation in
non-alcoholic steatohepatitis induced by high-fat diet in ratsMol
Med Rep4811816201121643627
|
|
9.
|
PS HsiehKC LuCF ChiangCH ChenSuppressive
effect of COX2 inhibitor on the progression of adipose inflammation
in high-fat-induced obese ratsEur J Clin
Invest40164171201010.1111/j.1365-2362.2009.02239.x20039930
|
|
10.
|
S ShishodiaG SethiBB AggarwalCurcumin:
getting back to the rootsAnn NY Acad
Sci1056206217200510.1196/annals.1352.01016387689
|
|
11.
|
SK YekolluR ThomasB O’SullivanTargeting
curcusomes to inflammatory dendritic cells inhibits NF-κB and
improves insulin resistance in obese
miceDiabetes6029282938201121885868
|
|
12.
|
SP WeisbergR LeibelDV TortorielloDietary
curcumin significantly improves obesity-associated inflammation and
diabetes in mouse models of
diabesityEndocrinology14935493558200810.1210/en.2008-026218403477
|
|
13.
|
A KoteishA Mae DiehlAnimal models of
steatohepatitisBest Pract Res Clin
Gastroenterol16679690200210.1053/bega.2002.0332
|
|
14.
|
TY LeeFY ChenHH ChangHC LinThe effect of
capillarisin on glycochenodexcholic acid-induced apoptosis and heme
oxygenase-1 in rat primary hepatocytesMol Cell
Biochem3255359200910.1007/s11010-008-0019-819132499
|
|
15.
|
TY LeeHH ChangJH ChenML HsuehJJ KuoHerb
medicine Yin-Chen-Hao-Tang ameliorates hepatic fibrosis in bile
duct ligation ratsJ
Ethnopharmacol109318324200710.1016/j.jep.2006.07.04216989967
|
|
16.
|
L TedescoA ValerioC CervinoA CardileC
PaganoR VettorR PasqualiMO CarrubaG MarsicanoB LutzCannabinoid type
1 receptor blockade promotes mitochondrial biogenesis through
endothelial nitric oxide synthase expression in white
adipocytesDiabetes5720282036200810.2337/db07-1623
|
|
17.
|
R GonzálezG FerrínAB HidalgoI RanchalP
López-CilleroM Santos-GónzalezG López-LluchJ BriceñoMA GómezA
PoyatoN-acetylcysteine, coenzyme Q10 and superoxide dismutase
mimetic prevent mitochondrial cell dysfunction and cell death
induced by d-galactosamine in primary culture of human
hepatocytesChem Biol Interact18195106200919523936
|
|
18.
|
GS HotamisligilInflammation and metabolic
disordersNature444860867200610.1038/nature0548517167474
|
|
19.
|
SE ShoelsonL HerreroA NaazObesity,
inflammation, and insulin
resistanceGastroenterology13221692180200710.1053/j.gastro.2007.03.05917498510
|
|
20.
|
C PosticJ GirardContribution of de novo
fatty acid synthesis to hepatic steatosis and insulin resistance:
lessons from genetically engineered miceJ Clin
Invest118829838200810.1172/JCI3427518317565
|
|
21.
|
S ParekhFA AnaniaAbnormal lipid and
glucose metabolism in obesity: implications for nonalcoholic fatty
liver
diseaseGastroenterology13221912207200710.1053/j.gastro.2007.03.05517498512
|
|
22.
|
MC ArkanAL HevenerFR GretenS MaedaZW LiJM
LongA Wynshaw-BorisG PoliJ OlefskyM KarinIKK-beta links
inflammation to obesity-induced insulin resistanceNat
Med11191198200510.1038/nm118515685170
|
|
23.
|
HM ArafaCurcumin attenuates diet-induced
hypercholesterolemia in ratsMed Sci Monit11228234200515990684
|
|
24.
|
A ShehzadT HaF SubhanYS LeeNew mechanisms
and the anti-inflammatory role of curcumin in obesity and
obesity-related metabolic diseasesEur J
Nutr50151161201110.1007/s00394-011-0188-121442412
|
|
25.
|
IA LeclercqGC FarrellC SempouxA dela PeñaY
HorsmansCurcumin inhibits NF-kappaB activation and reduces the
severity of experimental steatohepatitis in miceJ
Hepatol41926934200410.1016/j.jhep.2004.08.01015582125
|
|
26.
|
H InoueW OgawaM OzakiS HagaM MatsumotoK
FurukawaN HashimotoY KidoT MoriH SakaueRole of STAT-3 in regulation
of hepatic gluconeogenic genes and carbohydrate metabolism in
vivoNat Med10168174200410.1038/nm98014716305
|
|
27.
|
K UekiT KadowakiCR KahnRole of suppressors
of cytokine signaling SOCS-1 and SOCS-3 in hepatic steatosis and
the metabolic syndromeHepatol
Res33185192200510.1016/j.hepres.2005.09.032
|
|
28.
|
C DemeilliersC MaisonneuveA GrodetA
MansouriR NguyenM TinelP LettéronC DegottG FeldmannD PessayreB
FromentyImpaired adaptive resynthesis and prolonged depletion of
hepatic mitochondrial DNA after repeated alcohol binges in
miceGastroenterology12312781290200210.1053/gast.2002.3595212360488
|
|
29.
|
JM LiYC LiLD KongQH HuCurcumin inhibits
hepatic protein-tyrosine phosphatase 1B and prevents
hypertriglyceridemia and hepatic steatosis in fructose-fed
ratsHepatology5115551566201010.1002/hep.2352420222050
|
